XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues:      
Total revenues $ 213,578 $ 295,307 $ 335,001
Cost of goods sold:      
Product 117,352 148,866 108,935
Amortization of intangibles 36,042 31,515 36,401
Impairment of intangible asset 0 115,527 0
Total cost of goods sold 153,394 295,908 145,336
Operating expenses:      
Research and development 147,852 218,485 322,969
Selling, general and administrative 174,161 153,947 149,455
License expense 3,489 3,409 3,529
Total operating expenses 325,502 375,841 475,953
Operating loss (265,318) (376,442) (286,288)
Other income (expense):      
Interest income (expense) (19,936) (8,871) 792
Other income (expense) 2,414 1,856 (794)
Net loss before income taxes (282,840) (383,457) (286,290)
Benefit from income taxes 0 0 (6,631)
Net loss $ (282,840) $ (383,457) $ (279,659)
Net loss per share - basic (in dollars per share) $ (1.70) $ (2.77) $ (2.36)
Net loss per share - diluted (in dollars per share) $ (1.70) $ (2.77) $ (2.36)
Weighted-average number of common shares - basic (in shares) 165,949,695 138,463,152 118,395,919
Weighted-average number of common shares - diluted (in shares) 165,949,695 138,463,152 118,395,919
Comprehensive loss:      
Net loss $ (282,840) $ (383,457) $ (279,659)
Other comprehensive gain - unrealized gain on securities (7) 13 261
Total comprehensive loss (282,847) (383,444) (279,398)
Product revenue, net      
Revenues:      
Total revenues 142,216 128,901 111,119
License, collaboration and other revenue      
Revenues:      
Total revenues $ 71,362 $ 166,406 $ 223,882